STUDY QUESTION: Do assisted reproductive technologies alter DNA methylation and/or transcription of transposable elements and imprinted genes in cord blood and placenta?
Introduction
It is currently estimated that more than 5 million children have been born by assisted reproductive technologies worldwide (Hyrapetian et al., 2014) . Since almost 10% of couples are infertile (Boivin et al., 2007) , providing them with safe techniques to reach parenthood is a public health issue. However, ART has been associated with increased incidence of placenta-related adverse pregnancy outcomes, such as preeclampsia, intrauterine growth restriction (IUGR) and placenta praevia, even in singleton pregnancies of nulliparous women (Qin et al., 2016; Zhu et al., 2016) . Adverse perinatal outcomes, a higher risk of major malformations and imprinting disorders have also been reported in children born following ART (Hansen et al., 2005; Pinborg et al., 2013; Lazaraviciute et al., 2014) . These issues combined raise the question of a potential ART-induced epigenetic risk.
ARTs are used in the context of gametogenesis and preimplantation embryogenesis, which coincide with the establishment of genomic imprinting and transposable element (TE) control, through DNA methylation and other epigenetic modifications. Imprinted genes (IGs) are essential for regulating embryonic and placental development, through the control of nutrient exchange, metabolic processes and placental signalling Moore et al., 2015) . TEs are repeated sequences, representing around 50% of the human genome, and are potentially harmful if not properly controlled (Fauque and Bourc'his, 2014) . Human Endogenous Retroviruses (HERVs) are mostly immobile remnants of ancient elements but Long and Short Interspersed Nucleotide Elements (LINE and SINEs) can still generate de novo transposition events. In all cases, TEs can have important functions as cis regulatory modules (enhancers or promoters) for nearby genes (Hu et al., 2017) . Some studies have highlighted that preimplantation embryos could be particularly prone to transcriptional TE activation (Kano et al., 2009) and retrotransposition (van den Hurk et al., 2007) . LINE-1 loses methylation and gains expression in the placenta between the first and the third trimester (He et al., 2014) . Even more strikingly, specific ERVW and ERVFRD copies have been domesticated for their ability to produce fusogenic retroviral envelope proteins, the syncytins, which are essential for the formation of the syncytiotrophoblast (Bolze et al., 2017) . Altogether, there is strong evidence to suggest that TEs could be involved in placental functions and subsequent control of foetal growth and development.
We hypothesized that ART could affect the settlement of important developmental processes through epigenetic changes , thus triggering placenta-related adverse outcomes with potential longterm effects. This hypothesis was recently confirmed in mice (De Waal et al., 2015) . However, although some studies have reported subtle differences in the methylation or expression levels of IGs in human cord blood or placenta in ART-induced compared with spontaneous conception pregnancies (Tierling et al., 2010; Turan et al., 2010; Zechner et al., 2010; Rancourt et al., 2012; Nelissen et al., 2013; Vincent et al., 2016) , most of these have focused either on cord blood or placenta and have rarely reported combined expression and methylation analyses. Moreover, few studies have been interested in comparing conventional IVF to IVF with ICSI (Wong et al., 2011; Sakian et al., 2015; Vincent et al., 2016) .
To conclusively address the effect of ART on the epigenetic setting of the conceptus, we conducted a prospective study in which IGs and TEs were analysed for their DNA methylation and transcriptional levels in cord blood and placenta at birth, and compared the findings in singleton pregnancies obtained after IVF with those obtained following spontaneous conception pregnancies. We found methylation and/or transcription changes of some TEs and IGs in ART placenta samples, which could indicate an altered placental epigenetic regulation resulting from ART.
Materials and Methods

Study population
Patients were prospectively included from 1 January 2013 to 30 April 2015 in the Department of Obstetrics, Gynaecology and Reproductive Biology at Dijon University Hospital, France. Controls were singleton pregnancies achieved following spontaneous conception within 1 year after stopping contraception. IVF/ICSI patients were those with singleton pregnancies achieved following fresh embryo transfer after 2 days of in vitro culture. ICSI and IVF protocols were standardized (Desch et al., 2017) . At the time of conception, the mothers' and fathers' ages ranged from 20 to 43 and 18 to 50 years, respectively. Exclusion criteria were: pregnancies resulting from oocyte or sperm donation; foetuses with an abnormal karyotype; and maternal neurological, cardiac or pulmonary disorders, diabetes, hypertension, HIV or hepatitis B or C infections.
Clinical data collection
Clinical data concerning the mother's and father's history and treatments were collected prospectively during the ART procedures, throughout the pregnancy and after birth. Importantly, diseases occurring during pregnancy, as well as the characteristics of the placenta and the newborn at birth (weight, birth defects and neonatal data) were exhaustively recorded. Switzerland), according to the manufacturer's protocol, which includes a DNase digestion step. DNA was extracted from umbilical cord blood and placenta samples using a salting out method .
Sample preparation
Quantitative DNA methylation analyses
Three differentially methylated regions (DMRs) of IGs (H19/IGF2:IG-DMR, KCNQ1OT1:TSS-DMR and SNURF:TSS-DMR, named according to the recommendations for nomenclature; Monk et al., 2016) and four TE families (AluYa5, LINE-1Hs, ERVFRD-1 and ERVW-1) were studied by pyrosequencing. The DNA methylation assays investigated 3, 9, 7, 3, 3, 6 and 3 CpG sites, respectively (Table SI) ; each one included a conversion bisulphite treatment control and was tested with a DNA methylation scale (0-25-75-100%) obtained with EpiTect ® Control bisulphite-converted unmethylated/methylated DNA (human). Primers are available in Table SI . Bisulphite conversion of genomic DNA and pyrosequencing analysis were performed as previously described . Briefly, genomic DNA (750 ng) was modified using the Epitect Bisulfite Kit ® (Qiagen). Bisulphite-treated DNA (37.5 ng) was used as the template for PCR amplification. Pyrosequencing reactions were performed in a PyroMark Q24 MDx ® system (Pyrosequencing AB, Sweden) with the PyroGold Reagents kit ® (Qiagen). The DNA methylation level was calculated as the ratio of the C to T peaks at a given CpG site using PyroMark ® Q24 Software v.2.0.6 (Qiagen). To overcome potential between-plate variability, a common control was placed in each plate of pyrosequencing and the other DNA methylation values were normalized in accordance with this control.
Expression analysis
Real time-PCR was used to study the expression of genes associated with three DMRs (H19 for H19/IGF2 DMR, KCNQ1 for KCNQ1OT1 DMR and the common SNRPN and SNURF exons for SNURF DMR) and three TEs (the LINE-1 protein, ORF2; the envelope proteins of the two retroviruses ERVFRD-1 and ERVW-1, syncytin-2 and -1, respectively, and the sequence AluYa5). Expression was normalized on three housekeeping genes (GAPDH, SDHA and TBP). cDNA was synthesized using Maxima Reverse Transcriptase (Thermo Scientific ® ). The level of expression of each IG or TE (X) was normalized to the geometric mean of expression levels of three housekeeping genes, according to the formula:
, where Ct is the threshold cycle, and R1, R2, R3 are the housekeeping genes. Data were analysed with Bio-Rad CFX Manager (Version 3.0.1224.1015). Primers and conditions are listed in Table SII .
Statistical analyses
Categorical variables were expressed as numbers (percentages) 
Maternal characteristics
Age ( appropriate. Correlations between continuous variables were estimated using Spearman's rank correlation coefficients. Birth weights were converted into z-scores calculated using normal birth weight curves of our population accounting for gestational age and sex of the newborn (Rousseau et al., 2008) . Placental weights were also converted into z-scores according to gestational age and sex of the newborn (Thompson et al., 2007) . As recommended (Hogg et al., 2014) , multivariate analyses were adjusted for gestational age at delivery, sex of the newborn, parity and maternal age. Multiple regression linear models were used, after logtransformation of the dependent variable in the absence of normal distribution. All statistical analyses were performed with SAS software, v9.4 (SAS Institute Inc, USA). A two-tailed P < 0.05 was considered significant.
Ethical approval
All women had given written informed consent in accordance with the Declaration of Helsinki. The study was approved by the Institutional Review Board and the Ethics Committee of Dijon University Hospital (Comité de Protection des Personnes [CPP] Est I, n°2012-A01010-43).
Results
The demographic and obstetrical characteristics of the 99 pregnancies included are summarized in Table I .
DNA methylation of IG DMRs and TEs was decreased in the placenta of IVF/ICSI pregnancies
We studied two maternally inherited DMRs associated with the KCNQ1OT1 and SNURF loci, and one paternally methylated DMR at the H19/IGF2 locus. For TEs, we included two retroviruses (ERVFRD-1 and ERVW-1), whose involvement in placental function has been demonstrated (Bolze et al., 2017) , LINE-1 elements and SINEs AluYa5, the subfamily responsible for the majority of current Alu retrotransposition activity (Comeaux et al., 2009) .
We addressed the potential link between placental DNA methylation and clinical outcomes. In the whole study population, placental weight correlated positively with ERVFRD-1 methylation (r = 0.30, P = 0.0025; Fig. S1A ) while birth weight correlated positively with ERVFRD-1 and SNURF methylation (r = 0.23, P = 0.0259 and r = 0.20, P = 0.0481, respectively; Fig. S1B and C) .
The variability of DNA methylation was greater in both the cord blood and placenta of IVF/ICSI pregnancies than in samples from spontaneous pregnancies, as there were more outliers (<5%) in the ART group for H19/IGF2 DNA methylation in placenta (Table SIII) . DNA methylation of the studied IG DMRs and TEs in cord blood was not significantly different between groups (Fig. 1A, Table SIV ). By contrast, DNA methylation levels of LINE-1Hs, ERVFRD-1, H19/IGF2 and KCNQ1OT1 in placenta were lower in IVF/ICSI patients than in controls, even after adjustments (Fig. 1B, Table SIV ). For these regions, DNA methylation was globally lower in the IVF/ICSI group but some CpG sites seemed more affected than others (Fig. S2) . These differences were maintained after exclusion of the 11 IVF/ICSI patients and the four controls in which any pregnancy-associated disease had occurred: LINE-1Hs (P = 0.018), ERVFRD-1 (P = 0.047), H19/IGF2 (P = 0.020) and KCNQ1OT1 (P = 0.047). In addition, the effects of the four cases of 'vanishing twin' (two embryos implanted with one live birth only) and of the incidence of C-section were tested and did not modify these outcomes (data not shown).
Sex of the newborn had no effect on DNA methylation of any studied sequences, in cord blood or in placenta (Table SV) . The ART technique (IVF or ICSI) did not significantly modify DNA methylation in cord blood ( Fig. 2A , Table SVI ). In contrast, in placenta, after adjustment for gestational age at delivery, sex of the newborn, parity and maternal age, the DNA methylation of H19/IGF2 DMR was lower in IVF than in ICSI pregnancies (Fig. 2B, Table SVI) .
Expression of ERVFRD-1 was decreased in cord blood and placenta of IVF/ICSI pregnancies
To demonstrate the role of the studied IGs and TEs in the placental physiology, we studied the relationship between placenta weight, birth weight and gestational age at delivery and gene expression. Birth weight and placenta weight correlated positively with the expression of ERVFRD-1 in placenta ( Fig. 3A and B) in the spontaneous conception group only (no correlation in the IVF/ICSI group; Fig. 3C and D) . The gestational age at delivery correlated negatively with H19 expression in cord blood (r = −0.26; P = 0.0125; Fig. S3A ), this correlation was even stronger in the IVF/ICSI group (r = −0.43, P = 0.003; Fig.  S3B ). The gestational age at delivery also correlated negatively with ERVFRD-1 expression in placenta (r = −0.31, P = 0.0292; Fig. S4 ) in the IVF/ICSI group only.
For the expression of some TEs, the percentage of outliers was higher in cord blood and placenta samples from IVF/ICSI pregnancies than in samples from spontaneous pregnancies (Table SIII) . Expression levels of LINE-1 ORF2 and ERVFRD-1 in cord blood were significantly lower in IVF/ICSI than in controls (Fig. 4A , Table SVII ). The expression of other sequences was not different (Table SVII) . The expression level of ERVFRD-1 in placenta was also lower in IVF/ICSI than in controls (Fig. 4B , Table SVII) and this difference increased after the exclusion of women who experienced any pregnancy-associated disease (P = 0.002). In addition, the cases of 'vanishing twin' and C-section had no effect on expression outcomes (data not shown).
While the median relative expression of ERVFRD-1 was higher in the cord blood of boys than in the cord blood of girls (1.22 [0.83--1.62] vs. 0.91 [0.72-1.32], P = 0.008; Fig. S5A ), significant differences according to sex were not observed in the placenta (Fig. S5B) . The expression of LINE-1 ORF2 in cord blood was lower in IVF than in ICSI pregnancies (0.59 [0.55-0.64] vs. 0.89 [0.66-1.18], P = 0.016; Fig. S6A ) but we did not observe any significant difference in placental expression according to the ART mode (Fig. S6B) .
Discussion
By applying a robust methodology that included adjustment for potential confounding factors, our study revealed the occurrence of changes in the epigenetic regulation of IGs and TEs after ART, specifically lower DNA methylation for H19/IGF2 DMR, KCNQ1OT1 DMR, ERVFRD-1 and LINE-1 in placenta and lower ERVFRD-1 expression level in placenta and cord blood. To the best of our knowledge, this is the first report of altered regulation of TEs after ART.
Although the effect of ART on the regulation of IGs has been widely studied, the results are conflicting. Our findings show the absence of any effect of ART on the methylation status of IGs in cord blood, which is consistent with the majority of studies performed in mice (Fauque et al., 2010; De Waal et al., 2014) and humans (Tierling et al., 2010; Turan et al., 2010; Shi et al., 2011; Camprubi et al., 2013; Vincent et al., 2016) , with the exception of one study that found a slight but significant increase in KCNQ1OT1 methylation in IVF cord blood compared with controls (Rancourt et al., 2012) . However, in the placenta, we found that methylation of IGs was altered after ART, and in a locus-specific manner: KCNQ1OT1 and H19/IGF2 DMRs were less methylated in IVF/ICSI versus spontaneous conception, while SNURF DMR methylation may be considered as similar, after adjustments for confounding factors. Interestingly, De Waal et al. (2015) reported similar findings in mice analysed near term after IVF. Liver and brain foetal tissues displayed normal methylation profiles, while placentas were hypomethylated at the H19/Igf2 DMR but not at the Snrpn DMR. Other studies at the early stages of gestation have also reported IVF-induced H19 placental hypomethylation (Fauque et al., 2010; Wang et al., 2010; De Waal et al., 2014) with normal Snrpn methylation (De Waal et al., 2014) . In humans, most studies using bisulphite pyrosequencing agree with ours concerning placental H19/ IGF2 hypomethylation in the IVF/ICSI group (Rancourt et al., 2012; Nelissen et al., 2013) , unlike two studies that used other techniques (Wong et al., 2011; Camprubi et al., 2013) . Although several studies, like ours, found no difference in placental SNURF methylation (Camprubi et al., 2013; Nelissen et al., 2013) , others reported increased DNA methylation in the IVF group (Rancourt et al., 2012) . Moreover, although our findings of lower placental DNA methylation of H19/IGF2 in IVF compared with ICSI have not been evidenced by other studies (Wong et al., 2011; Nelissen et al., 2013; Sakian et al., 2015) , other works suggest that more changes occur in IVF than in ICSI in cord blood for PLAGL1 and MEST (Tierling et al., 2010; Vincent et al., 2016) . This highlights the need for further study in comparing both techniques.
These differences between studies can be explained by the different methodologies used: population samples, merging of different ART techniques and protocols, and the lack of adjusted analyses are Figure 1 DNA methylation of the studied differentially methylated regions of imprinted genes and transposable elements in cord blood (A) was similar in both groups. DNA methylation levels of LINE-1Hs, ERVFRD-1, H19/IGF2 and KCNQ1OT1 were lower in the placenta (B) of IVF/ICSI patients (purple) than in the spontaneous conception group (green). Each box represents the interquartile range (IQR). Lines inside the boxes are the median. Whiskers represent the 10th and 90th percentiles. Crosses represent the mean. P-values are the results of multiple regression linear models adjusting for maternal age and parity, gestational age at delivery and sex of the newborn. NS: non-significant.
limitations of these studies (Lazaraviciute et al., 2014) . By contrast, our monocentric and prospective design ensures high consistency in laboratory techniques, accurate data collection and standardized samples. Furthermore, the two cohorts were very homogeneous, as the IVF/ICSI group included only singleton pregnancies achieved following the transfer of fresh 2-day-old embryos cultured in a unique medium and the control group included only spontaneous pregnancies achieved within 1 year. The statistical analysis adjusted for various confounding factors such as gestational age at delivery, sex of the newborn, maternal age and parity.
The existence of an imprinted gene network (IGN) could also explain the heterogeneity of the results reported (Varrault et al., 2006; Fauque et al., 2010; Iglesias-Platas et al., 2014) . The IGN includes a myriad of genes with similar roles controlling essential functions such as foetal nutrition and growth. Thanks to its genetic 'redundancy' (Yuen and Robinson, 2011) , the failure of some IGs can be compensated by the expression of others. We recently hypothesized that, in response to primary dysfunctions mediated by ART, the placenta could adapt throughout the pregnancy, with the adaptation being mediated by epigenetic modifications, especially in the IGN . The increased variation after IVF/ICSI found in our study and in others (Camprubi et al., 2013; Melamed et al., 2015) clearly illustrate this plasticity. The similarity of birth weight in the two groups and the lack of DNA methylation or expression differences in IGs in cord blood also suggest that the foetus is protected against major modifications. In addition, despite DNA methylation changes at H19/ IGF2 and KCNQ1OT1 DMRs, the lack of transcriptional modifications of H19 and KCNQ1 in the placenta at birth and the negative correlation between H19 expression and gestational age at delivery strengthens the hypothesis of dynamic adaptation throughout pregnancy. The sequence of events is better demonstrated in animal studies. Fortier's team investigated the effects of superovulation in mice on the expression of Igf2 in the placenta and observed a significant increase at E9.5, which became non-significant at E14.5 and disappeared near term (Fortier et al., 2008 (Fortier et al., , 2014 . We can postulate that levels of expression may have returned to normal at birth or some modifications may Figure 2 DNA methylation of the studied differentially methylated regions of imprinted genes and transposable elements in cord blood (A) was similar in IVF and ICSI groups. DNA methylation levels of H19/IGF2 were lower in the placenta (B) of IVF patients (dark purple) than in ICSI patients (light purple). Each box represents the interquartile range (IQR). Lines inside the boxes are the median. Whiskers represent the 10th and 90th percentiles. Crosses represent the mean. P-values are the results of multiple regression linear models adjusting for maternal age and parity, gestational age at delivery and sex of the newborn. NS: non-significant. persist depending on the severity of the primary injury and on the efficacy of the adaptation mechanisms.
Our novel findings concerning the expression and methylation of the retrovirus ERVFRD-1 indicate that IGN may not be the only pathway involved in placental adaptation. Indeed, human endogenous retroviruses ERVW-1 and ERVFRD-1 encode envelope glycoproteins called syncytin-1 and syncytin-2, respectively. They are known to be involved in cell fusion, particularly the fusion of cytotrophoblasts, a necessary step in the formation of a placental exchange area called the syncytiotrophoblast. Their immunosuppressive properties could also contribute to maternal tolerance towards the foetus (Tolosa et al., 2012; Lokossou et al., 2014) . Furthermore, they are involved in pregnancyassociated diseases: the level of syncytin-2 in exosomes from maternal blood is decreased in preeclampsia (Vargas et al., 2014) and placental expression of syncytin-1 and -2 is decreased in IUGR and preeclampsia (Bolze et al., 2017) . Interestingly, ovarian stimulation could affect their regulation, as syncytin-1 has been shown to be up-regulated by progesterone (Noorali et al., 2009 ). In our study, ERVFRD-1 methylation was decreased in placenta after IVF/ICSI while its expression was decreased in both cord blood and in placenta. Furthermore, the expression of ERVFRD-1 in placenta correlated positively with birth weight and placenta weight, but only in the control group. It can be argued that foetal growth could be linked to placental ERVFRD-1 expression in normal pregnancies, while syncytin-2 regulation could be impaired after IVF/ICSI. This hypothesis is strengthened by the negative correlation between the expression level of ERVFRD-1 in placenta and the gestational age at delivery for IVF/ICSI pregnancies, which shows that, as the pregnancy progresses, the level of syncytin-2 decreases. Altogether, these data suggest that compensatory mechanisms implicating syncytins, such as an increase in cell fusion mediated by ERVFRD-1 in placenta, play a fundamental role in placental physiology, and may be promoted in IVF/ICSI by hypomethylation of its Figure 3 Correlations between ERVFRD-1 expression in placenta and z-score of birth weight (A) and z-score of placenta weight (B), in the spontaneous conception group. Absence of correlation between ERVFRD-1 expression in placenta and z-score of birth weight (C) and z-score of placenta weight (D), in the IVF/ICSI group. promotor although they are possibly exhausted at the end of the pregnancy following ART.
For future research, we should broaden the vision of epigenetic regulation in the placenta, which has been limited to DNA methylation in our study. Further studies are needed to assess the role of other actors such as small RNAs and histones modifications, whose implication on placental physiology has been demonstrated (Kohan-Ghadr et al., 2016) . Further studies should also focus on an infertile population as a control group. Indeed, since infertility alone might also trigger epigenetic changes (Litzky et al., 2017) , the control group of fertile couples having conceived within 1 year prevented us from deciphering the distinct roles of ART and infertility. As studies have demonstrated a link between maternal diet and modifications of the offspring's epigenome (van Dijk et al., 2016) , a better control of factors such as parental diet or prenatal care would also be valuable.
To conclude, although syncytins were already known to be involved in placental physiology and pathologies, to our knowledge, this is the first report of positive correlations between syncytin-2 expression in placenta and birth/placenta weight and of ART affecting syncytin-2 regulation. More research about the link between syncytins and pregnancy-associated diseases such as IUGR and preeclampsia could lead to them being used as biomarkers or even as therapeutic targets. This is also the first study to address both the methylation and expression of TEs and IGs in cord blood and placenta at birth. The slight but significant differences between the groups for some placental TEs and IGs methylation suggest that ART modifies placental epigenetic regulation. As TEs and IGs are known to be involved in foetal and placental development, their dysregulation could contribute to explain the increased rate of placenta-related adverse pregnancy outcomes after ART. Even though all of the newborns were healthy and no transcriptional differences were evidenced in IGs at birth, the repercussions of the original injury could be mitigated by compensatory epigenetic mechanisms mediated by the placenta throughout pregnancy. More research is needed to reveal the sequence of events occurring during pregnancy. Since the intrauterine environment could affect the individual later in life (Developmental Origins of Health and DiseaseDOHaD-theory) (Barker, 2007) , there is the question of the potential long-term effects of these epigenetic modifications. All in all, these results should encourage us to analyse the exact causes and consequences of epigenetic changes and strive to minimize these variations in the interest of epigenetic safety after ART.
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